IRVING S. WRIGHT, M.D., F.A.C.P.
The use of anticoagulant therapy in the treatment of myocardial infarction is rapidly becoming accepted in medical centers and leading hospitals throughout the civilized world.1 It is also being used well in many small communities where there exists the fortunate combination of a well trained, conscientious physician and a good laboratory capable of performing accurate prothrombin time tests.2 While the report of the Committee on Anticoagulants of The American Heart Association constitutes the most comprehensive and detailed evaluation of this therapy, reports from more than 40 institutions confirming this study have appeared from the United States and foreign countries. In
WRIGHT IS. PRESENT STATUS OF ANTICOAGULANT THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION; THE USE AND MISUSE OF ANTICOAGULANTS; AN EVALUATION OF NEW ANTICOAGULANTS, THEIR INDICATIONS AND DOSAGE(PRESENT STATUS OF ANTICOAGULANT THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION; THE USE AND MISUSE OF ANTICOAGULANTS; AN EVALUATION OF NEW ANTICOAGULANTS, THEIR INDICATIONS AND DOSAGE*). Ann Intern Med. 1955;43:942–954. doi: 10.7326/0003-4819-43-5-942
Download citation file:
Published: Ann Intern Med. 1955;43(5):942-954.
Acute Coronary Syndromes, Cardiology, Coronary Heart Disease, Emergency Medicine.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use